Stock GBIM GLOBEIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GlobeImmune, Inc.

Equities

GBIM

US37957B1008

Delayed OTC Markets
Other stock markets
 02:43:20 2024-03-14 pm EDT 		5-day change 1st Jan Change
0.000001 USD -99.00% Intraday chart for GlobeImmune, Inc. -.--% -.--%
2022 Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital announced an offer to acquire 12.2% stake in GlobeImmune, Inc. for $7,000. CI
2017 NantCell, Inc. Exercises Option for Licensing Agreement with GlobeImmune, Inc. for GI-6100 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GLOBEIMMUNE, INC. Stock GlobeImmune, Inc.
 5 - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. GBIM Stock
  4. Charts GlobeImmune, Inc.
  5. Sector Chart